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Supplemental oxygen:  
More isn’t always better 
A recent study says that in certain populations, 
supplemental oxygen above certain levels can increase 
mortality. 
PRACTICE CHANGER
Do not use liberal oxygen therapy (SpO2 
> 96%) in acutely ill adults, as it is associated 
with increased all-cause mortality.1 
STRENGTH OF RECOMMENDATION 
A: Based on a systematic review and meta-
analysis of 25 randomized controlled trials. 
Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill 
adults treated with liberal versus conservative oxygen therapy (IOTA): 
a systematic review and meta-analysis. Lancet. 2018;391:1693-1705.
ILLUSTRATIVE CASE
A 60-year-old woman who is generally healthy 
except for a history of recurrent urinary tract 
infections presents to the emergency depart-
ment with fever, hypotension, and altered 
mental status, meeting criteria for septic 
shock. During her resuscitation, supplemen-
tal oxygen is administered. Standard treat-
ment calls for a minimum SpO2 (saturation of 
peripheral oxygen) > 90%. What should your 
SpO2 goal be? 
Use of supplemental oxygen in the acute care of the critically ill adult is a common practice in pre-hospital, 
emergency department (ED), and hospital-
ized settings.2,3 Despite their prevalence, 
guidelines about appropriate oxygen concen-
tration and target SpO2 levels are often con-
flicting or vague.3-5
Excessive oxygen supplementation 
in acute illness may be harmful and cause 
increased risk of hypercapnic respiratory 
failure, delayed recognition of clinical deteri-
oration, and oxygen toxicity.2,6 The perception 
of oxygen safety persists despite these find-
ings, and it likely contributes to the ongoing 
practice of liberal oxygen supplementation in 
the acutely ill adult.2,7,8 
STUDY SUMMARY
Liberal supplemental O2  
linked to increased mortality
The Improving Oxygen Therapy in Acute ill-
ness (IOTA) study was a systematic review 
and meta-analysis of 25 randomized con-
trolled trials (RCTs) that compared liberal vs 
conservative oxygen strategies for acutely ill 
adults (N = 16,037; median age = 64 years; 
range = 28-76 years). Patients with sepsis, 
critical illness, stroke, trauma, myocardial in-
farction, or cardiac arrest, and patients who 
had emergency surgery were included. Stud-
ies were excluded if they involved patients 
who had chronic respiratory illness or psychi-
atric diseases, were receiving extracorporeal 
membrane oxygenation, were undergoing 
elective surgeries, were being treated with 
hyperbaric oxygen therapy, or were pregnant. 
The outcomes studied were mortal-
ity (in-hospital, at 30 days, and at the longest 
 follow-up) and morbidity (disability mea-
sured by the modified Rankin Scale at longest 
follow-up, risk of hospital-acquired pneumo-
nia, risk of any hospital-acquired infection, 
and hospital length of stay). 
Liberal supplemental oxygen, above an 
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SpO2 range of 94% to 96%, increased mortality 
during inpatient stays (relative risk [RR] = 1.21; 
95% confidence interval [CI], 1.03-1.43; N = 
15,071), at 30 days (RR = 1.14; 95% CI, 1.01-1.29; 
N = 15,053), and at longest follow-up (RR = 1.10; 
95% CI, 1.00-1.20; N = 15,754; median = 90 days; 
range = 14,365 days). There was no difference in 
morbidity outcomes between groups. 
While it’s difficult to define a specific target 
SpO2 range, the number needed to harm when 
using a liberal oxygen approach (SpO2 > 96%) re-
sulting in 1 death was 71 (95% CI, 37-1000).
WHAT’S NEW
High-quality evidence points  
to the dangers of liberal O2 therapy
This comprehensive meta-analysis is the first 
high-quality evidence to suggest that liberal 
use of oxygen in acutely ill adults above a spe-
cific SpO2 level increases all-cause mortality. 
Previous small RCTs and observational studies 
have examined the effect of liberal oxygen only 
on specific presenting conditions, thus making 
more generalizable conclusions challenging.9-12
CAVEATS
Varied definitions of  
“liberal” and “conservative”
This review included studies with variable 
ranges of SpO2 defined as liberal vs conser-
vative supplementation. However, in all of 
these, SpO2 above 96% was correlated with 
unfavorable outcomes.
The study excluded 2 potentially impor-
tant patient groups: patients with chronic 
respiratory diseases and pregnant patients. 
Increased oxygen supplementation in pa-
tients with chronic respiratory diseases in 
noncritical settings has been shown to be 
deleterious.13-15 While this study does not ad-
dress the issue of oxygen supplementation in 
acutely ill patients with chronic respiratory 
disease, use should be considered with cau-
tion. The results from this study may not be 
generalizable to women who are pregnant. 
CHALLENGES TO IMPLEMENTATION
Reversing the tide
Liberal oxygen administration continues to 
be practiced in many health care settings. 
The main challenges to implementing the 
conclusions of this study are these pervasive 
practices.                   JFP 
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This  meta-
analysis is the 
first high-quality 
evidence to 
suggest that 
liberal use 
of oxygen in 
acutely ill adults 
above a specific 
SpO2 level 
increases all-
cause mortality.
